Prickly heat — known clinically as miliaria — is one of the most common skin complaints pharmacists encounter during the warmer months. It occurs when sweat ducts become blocked, trapping perspiration beneath the skin and producing clusters of small, itchy red bumps. While rarely dangerous, the discomfort can be significant, and patients frequently seek pharmacy advice before considering a GP appointment.
What Causes Prickly Heat?
Miliaria develops when eccrine sweat glands become occluded, usually by a combination of heat, humidity and friction. The condition is most common in skin folds — the neck, groin, under the breasts, and in elbow creases — though it can appear anywhere on the body.
Three clinical forms are recognised:
| Type | Depth of blockage | Appearance | Severity |
|---|---|---|---|
| Miliaria crystallina | Superficial (stratum corneum) | Tiny clear vesicles, no inflammation | Mild — usually self-resolving |
| Miliaria rubra | Mid-epidermis | Red papules, intense itch and prickling | Moderate — most common presentation |
| Miliaria profunda | Dermal-epidermal junction | Flesh-coloured papules, less itch | Uncommon in the UK climate |
According to NHS guidance, miliaria rubra is the form most patients present with in community pharmacy. It typically resolves within days once the skin is cooled and kept dry, but targeted OTC treatment can reduce symptoms substantially.
Who Is Most at Risk?
Certain groups are disproportionately affected:
- Infants and young children — immature sweat ducts are more easily blocked
- People who are overweight or obese — greater skin-fold occlusion
- Patients on medications that impair sweating — anticholinergics, beta-blockers and some antipsychotics can alter thermoregulation
- Those wearing occlusive dressings or tight clothing — trapping heat against the skin
- People new to hot climates — UK travellers abroad are a common summer pharmacy presentation
Pharmacists should be alert to medication-related risk factors. A patient on oxybutynin or amitriptyline presenting with heat rash may benefit from a medication review conversation with their prescriber, particularly if episodes are recurrent.
Pharmacy Treatment Options
Calamine lotion
Calamine remains a first-line symptomatic treatment for prickly heat. Applied directly to affected areas, it provides a cooling effect as it evaporates and helps reduce itching. It is safe for use in adults and children over one month of age according to BNF guidance. Patients should be advised to shake the bottle before use and apply with cotton wool rather than rubbing into the skin.
Hydrocortisone cream 1%
For more inflamed presentations — where red papules are raised and the itch is disrupting sleep or daily activities — hydrocortisone 1% cream can be supplied over the counter. The standard recommendation is to apply a thin layer to affected areas twice daily for up to seven days. It should not be used on the face in children under 10 years, and pharmacists should confirm the patient is not already using a prescribed topical steroid.
Antihistamines
Oral antihistamines such as cetirizine or chlorphenamine can help manage itch, particularly at night. Chlorphenamine's sedating properties may be beneficial for patients whose sleep is disrupted, though daytime drowsiness should be discussed. Non-sedating options such as cetirizine 10mg or loratadine 10mg are generally preferred for daytime use.
Cooling measures
The most effective intervention is also the simplest: cool the skin. Advise patients to:
- Take lukewarm (not cold) showers or baths
- Wear loose, cotton clothing
- Use a fan or air conditioning where available
- Avoid heavy moisturisers or oil-based products that can further occlude pores
- Pat skin dry rather than rubbing
When to Refer
Most cases of prickly heat resolve with OTC treatment and environmental changes within a few days. Pharmacists should refer to a GP if:
- The rash persists beyond seven days despite treatment
- There are signs of secondary bacterial infection — increasing redness, warmth, swelling, pus or crusting
- The patient develops a fever alongside the rash
- The rash is widespread and affecting large areas of the body
- The patient is immunocompromised or on immunosuppressive medication
Infected miliaria (miliaria pustulosa) requires antibiotic treatment and falls outside the scope of pharmacy supply.
Prevention Advice
Pharmacists can offer proactive advice during warmer months:
- Stay in cool, well-ventilated environments during peak heat (11am–3pm)
- Apply lightweight, non-comedogenic sunscreen rather than heavy formulations
- Change out of damp or sweaty clothing promptly
- Use talc-free powder in skin folds to absorb moisture
- Stay hydrated — adequate fluid intake supports normal thermoregulation
For patients travelling to tropical destinations, advise a gradual acclimatisation period rather than immediate prolonged sun exposure.
The Pharmacy Role
Community pharmacists are ideally placed to manage prickly heat presentations efficiently, sparing GP appointments for more complex conditions. With appropriate product selection and clear self-care advice, most patients can expect symptom resolution within 48 to 72 hours. For those working in pharmacy, understanding the seasonal pattern of presentations — with a predictable surge during UK heatwave periods and the summer holiday season — allows proactive stock management and counter display planning.
Explore pharmacy services near you using the PharmSee pharmacy finder, or browse current pharmacy job opportunities across the UK.